Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
Abstract Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is the only state-of-art treatment option for CUP patients. The molecular profiling of the tumour, particularly mutation detection, offers a...
Saved in:
Main Authors: | Hamidreza Aboulkheyr Es, Hamid Mahdizadeh, Amir Abbas Hedayati Asl, Mehdi Totonchi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f1fe39e7ef8448c2826eda7bf9a46cfb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS mutation: from undruggable to druggable in cancer
by: Lamei Huang, et al.
Published: (2021) -
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
by: Mark Manzano, et al.
Published: (2018) -
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
by: Matthias Balk, et al.
Published: (2021) -
Melanoma Targeted Therapies beyond <i>BRAF</i>-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
by: Karam Khaddour, et al.
Published: (2021) -
Identification of druggable cancer driver genes amplified across TCGA datasets.
by: Ying Chen, et al.
Published: (2014)